Top Markets
Coin of the day
Everest Organics Limited Everest Organics Limited

Everest Organics Limited

EVERESTO
Rank in Stocks #27609
Everest Organics Limited is a pharmaceutical enterprise specializing in the... Everest Organics Limited is a pharmaceutical enterprise specializing in the production of bulk drugs. Its product line encompasses compounds such as Omeprazole, Ciprofloxacin, Dichloroflurobenzene, and Benzimadizole. Additionally, the company manufactures and exports active pharmaceutical ingredients (APIs) and their intermediates from its facilities in India, supplying these to formulation companies worldwide. The firm was founded on February 19, 1993, and its headquarters are located in Hyderabad, India.
Share Price
$3.45
Market Cap
$33.54M
Change (1 day)
5.55%
Change (1 year)
-25.58%
Country
IN
Trade Everest Organics Limited (EVERESTO)

Category

Revenue for Everest Organics Limited (EVERESTO)
Revenue in Aug 2026 TTM: 0
According to Everest Organics Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Everest Organics Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$410.98B -
US
- -
US
$254.25B -
US
- -
US
$3.67B -
AU